IOL Chemicals and Pharmaceuticals Share Price

IOL Chemicals and Pharmaceuticals Share Price

NSE: IOLCP
|
Pharmaceuticals

₹ 195.11

-₹3.55 (-1.79%)
1D
Last updated 13 Oct, 2026, 15:59 IST

IOL Chemicals and Pharmaceuticals Share Price Today

As of 13 Oct 2026, IOL Chemicals and Pharmaceuticals share price is ₹195.11. The stock opened at ₹196.75, compared to its previous close of ₹198.66. During today's trading session, IOL Chemicals and Pharmaceuticals share price moved in the range of ₹188.61 to ₹196.77, with an average price of ₹192.69 for the day. Looking at its last 52-week, the stock has touched a low of ₹67.19 and a high of ₹224.00. On the performance front, IOL Chemicals and Pharmaceuticals share price has increased by 141.91% over the last six months and is up 94.88% on a year-on-year basis.

₹188.61
1.79% down today
₹196.77
1D LOW
1D HIGH

IOL Chemicals and Pharmaceuticals Returns Calculator

Volume
25,45,371
Average traded price
₹193.08
Last traded time
03:59:51 13 Oct
Last traded quantity
16
Circuit
L
H
₹158.93
₹238.39
52-week
L
H
₹67.19
₹224.00
Mkt Cap Cr
5,895.50
P/E
34.58
P/B
3.23
ROA
6.5%
ROE
7.65%
ROCE
10.29%
Quick Ratio
1.24
EV/EBITDA
18.18
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
IOL Chemicals outperforming all market indices
Step 1 of 5
Valuation
Overvalued
IOL Chemicals appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
IOL Chemicals revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,067.0134.835.0511.19%13.74%17.33%2.3121.42
Divis Laboratories2,48,982.9885.1214.8514.6%15.32%19.56%3.556.28
Torrent Pharmaceuticals1,77,251.4282.5521.164.87%25.49%13.85%0.7538.11
Zydus Lifesciences1,13,615.6924.744.198.57%18.59%17.35%0.9114.87
Laurus Labs1,11,898.66102.6321.1110.38%16.77%16.14%0.6853.86
Cipla1,06,129.9631.623.087.92%11.27%14.95%2.517.83
Dr. Reddy's Laboratories1,02,707.4132.262.75.48%11.07%12.54%1.3515.86
Mankind Pharma99,089.5247.926.087.36%11.74%13.13%0.7425.7
Aurobindo Pharma97,972.4726.42.596.34%9.25%11.76%1.1512.47
Lupin89,628.8316.033.9614.47%23.76%24.88%1.429.56

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About IOL Chemicals and Pharmaceuticals

IOL Chemicals and Pharmaceuticals Share Price
ISIN
INE485C01029
Sector Market Cap
₹ 5,895.50 Cr

IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of pharmaceutical and chemical products. The Company operates through two segments: Chemical and Pharmaceutical. The Chemical segment produces and sells Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride, Mono Chloro Acetic Acid, Para Amino Phenol (PAP), and others. The Pharmaceutical segment produces and sells various active pharma ingredients (API) including Ibuprofen, Metformin, Fenofibrate, Lamotrigine, Clopidogrel Bisulphate, Pantoprazole, Gabapentin, Paracetamol, and others. Its API product portfolio includes Pantoprazole Sodium, Clopidogrel Bisulphate (Form II), Losartan Potassium, Levetiracetam, and Fenofibrate (Micronised). Its Specialty Chemical division includes Ethyl Acetate, Iso Butyl Benzene, Mono Chloro acetic Acid, and Acetic Anhydride. Its Ethyl Acetate is used in industries like flexible packaging, pharmaceuticals, ink, food processing, pesticides, and the paint industry.

IOL Chemicals and Pharmaceuticals Financial Highlights

  • Revenue: IOL Chemicals and Pharmaceuticals reported revenue of ₹2,340.44 crore in FY26 vs ₹2,101.62 crore in FY25. It showed an increase of 11.36% on a yearly basis.
  • Operating Profit: IOL Chemicals and Pharmaceuticals reported an operating profit of ₹184.36 crore in FY26 vs ₹137.96 crore in FY25. It showed an increase of 33.63% on a year-on-year basis.
  • Net Profit: IOL Chemicals and Pharmaceuticals reported a net profit of ₹137.64 crore in FY26 vs ₹101.07 crore in FY25. It showed an increase of 36.18% on a yearly basis.

IOL Chemicals and Pharmaceuticals Quarterly Result Highlights

  • IOL Chemicals and Pharmaceuticals reported revenue of ₹764.44 crore in Jun 2026, compared with ₹621.29 crore in Mar 2026, representing an increase of 23.04% on a quarter-on-quarter (QoQ) basis.
  • IOL Chemicals and Pharmaceuticals reported an operating profit of ₹86.69 crore in Jun 2026, compared with ₹70.81 crore in Mar 2026, representing an increase of 22.43% on a quarter-on-quarter (QoQ) basis.
  • IOL Chemicals and Pharmaceuticals reported a profit of ₹64.40 crore in Jun 2026, compared with ₹53.16 crore in Mar 2026, reflecting an increase of 21.14% on a QoQ basis.
  • The earnings per share (EPS) of IOL Chemicals and Pharmaceuticals stood at ₹4.69 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
62.28%
FII
7.25%
Other DII
0.01%
Retail and other
30.17%
Mutual funds
0.29%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20252.08%
Mar 20261.72%
Jun 20264.87%
Sep 20267.25%
1 day
-1.24%
1 week
-3.43%
1 month
+2.24%
1 year
+94.88%
3 years
+107.35%
5 years
+68.37%
Day
Open / Close
Change %
12 Oct 26
₹202.00 / ₹198.66
-1.24%
09 Oct 26
₹206.10 / ₹201.15
-2.14%
08 Oct 26
₹220.41 / ₹205.55
-6.66%
07 Oct 26
₹216.50 / ₹220.22
+2.48%
Show more

IOL Chemicals and Pharmaceuticals Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,319.06₹2,079.21₹2,132.79₹2,217.11
Other Income₹21.38₹22.41₹30.07₹25.61
Total Revenue₹2,340.44₹2,101.62₹2,162.86₹2,242.72
Total Expenses₹2,144.87₹1,963.66₹1,981.21₹2,054.07
Profit Before Tax₹184.36₹137.96₹181.65₹188.65
Tax₹46.72₹36.89₹47.22₹49.51
Profit After Tax₹137.64₹101.07₹134.43₹139.14
EPS - Basic₹4.69₹3.44₹4.58₹23.70
EPS - Diluted₹4.69₹3.44₹4.58₹23.70

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹184.36₹137.96₹181.65₹188.65
Income before WC changes₹269.40₹217.81₹241.47₹233.06
Change in Assets-₹83.91₹25.18-₹71.66₹41.30
Change in Liabilities₹66.69-₹46.05₹161.99-₹104.99
Change in WC-₹17.22-₹20.87₹90.33-₹63.69
Cash flow from Operations₹214.32₹178.62₹289.78₹122.27
Cash flow from Investing-₹198.11-₹154.18-₹190.98-₹120.00
Cash flow from Financing-₹29.03₹46.04-₹92.50-₹4.11
Total Cash Flow-₹12.82₹70.48₹6.30-₹1.84
Cash (Start of the year)₹78.17₹7.69₹1.39₹3.23
Cash (End of the year)₹65.35₹78.17₹7.69₹1.39

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,359.32₹1,230.73₹1,124.63₹1,101.74
Current Assets₹1,227.63₹1,151.34₹1,119.77₹920.39
Total Assets₹2,586.95₹2,382.07₹2,244.40₹2,022.13
Current Liabilities₹690.18₹609.91₹560.00₹456.26
Net Current Asset₹537.45₹541.43₹559.77₹464.13
Non-Current Liabilities₹98.22₹84.50₹72.89₹58.15
Equity Capital₹1,798.55₹1,687.66₹1,611.51₹1,507.72
Total Equity & Liabilities₹2,586.95₹2,382.07₹2,244.40₹2,022.13

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,319.06₹2,079.21₹2,132.79₹2,217.11
Other Income₹21.28₹22.40₹30.07₹25.57
Total Revenue₹2,340.34₹2,101.61₹2,162.86₹2,242.68
Total Expenses₹2,144.69₹1,963.72₹1,980.22₹2,053.19
Profit Before Tax₹184.44₹137.89₹182.64₹189.49
Tax₹46.72₹36.89₹47.22₹49.51
Profit After Tax₹137.72₹101.00₹135.42₹139.98
EPS - Basic₹4.69₹3.44₹4.61₹23.84
EPS - Diluted₹4.69₹3.44₹4.61₹23.84

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹184.44₹137.89₹182.64₹189.49
Income before WC changes₹269.52₹217.67₹242.40₹233.91
Change in Assets-₹83.79₹25.18-₹71.90₹41.67
Change in Liabilities₹66.55-₹45.85₹161.98-₹105.34
Change in WC-₹17.24-₹20.67₹90.08-₹63.67
Cash flow from Operations₹214.42₹178.68₹290.46₹123.14
Cash flow from Investing-₹198.12-₹154.23-₹191.39-₹119.19
Cash flow from Financing-₹29.03₹46.04-₹92.50-₹4.11
Total Cash Flow-₹12.73₹70.49₹6.57-₹0.16
Cash (Start of the year)₹78.02₹7.53₹0.96₹1.12
Cash (End of the year)₹65.29₹78.02₹7.53₹0.96

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,359.21₹1,230.66₹1,124.49₹1,101.54
Current Assets₹1,227.51₹1,151.12₹1,119.48₹919.07
Total Assets₹2,586.72₹2,381.78₹2,243.97₹2,020.61
Current Liabilities₹690.12₹609.87₹559.75₹455.91
Net Current Asset₹537.39₹541.25₹559.73₹463.16
Non-Current Liabilities₹98.22₹84.50₹72.89₹58.15
Equity Capital₹1,798.38₹1,687.41₹1,611.33₹1,506.55
Total Equity & Liabilities₹2,586.72₹2,381.78₹2,243.97₹2,020.61
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
195.11
4615
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 4615
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
3
Bullish
4
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
49.41
Neutral
ATR (14)
10.8
Neutral
STOCH(9,6)
10.68
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
18.15
Bullish
UO(9)
40.16
Neutral
ROC(12)
-3.84
Bearish
WillR(14)
-82.97
Bullish
Period
Simple value
Exponential vaue
5D
208.1
204.31
10D
206.04
205.16
20D
202.34
202.51
50D
187.03
188.37
100D
164.17
166.15
Volume trend — traded volume by day
13 Oct25L
12 Oct17L
9 Oct27L
8 Oct41L
7 Oct63L
6 Oct38L
Average35L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
IOL Chemicals and Pharmaceuticals Share Price
IOL Chemicals and Pharmaceuticals
Pharmaceuticals
Add Stock
Add Another

IOL Chemicals and Pharmaceuticals Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.